Vraylar 4.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FC83G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,363
Award facts
- Contract value 100% obligated
- $11,362.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,362.78 to AmerisourceBergen Drug Corp for the supply of Vraylar 4.5 mg capsules (30-count units), with a firm fixed price structure and an ultimate completion date of August 26, 2025. This non-set-aside, competitively awarded contract reflects DLA's ongoing pharmaceutical procurement needs for military and federal healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical supply chains, and this delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026.
The delivery order represents a discrete pharmaceutical fulfillment within AmerisourceBergen Drug Corp's comprehensive global pharmaceutical support vehicle, which enables the company to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. Vraylar is a neurological treatment medication, consistent with AmerisourceBergen Drug Corp's demonstrated portfolio of therapeutic products spanning diabetes management, pain management, antibiotics, and specialty pharmaceuticals. The company's consistent receipt of competitive, non-set-aside awards across multiple therapeutic domains demonstrates its established capability to meet federal procurement standards and serve customers including the Defense Health Agency and U.S. Coast Guard through flexible contract mechanisms.
Quick answers
Who was awarded contract SPE2DB25FC83G?
SPE2DB25FC83G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FC83G worth?
The government has obligated $11,363 on SPE2DB25FC83G.
Is contract SPE2DB25FC83G an order under another contract?
Yes. SPE2DB25FC83G is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FC83G competed?
The extent of competition for SPE2DB25FC83G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award